Pomalidomide — Dosing in CKD & Dialysis

Pomalidomide (Antineoplastic): renal dosing adjustments, dialyzability (Removed by hemodialysis: estimated dialysis clearance about 12 L/h, higher than total body clearance (7-10 L/h) (label 10, 12.3)), and renal-relevant safety risk for CKD and dialysis patients. Educational reference for nephrolog

Reviewed by Matt · November 16, 2026

NephroResource

Taking longer than expected

If you're on a slow connection or this keeps happening, tap below to reload.